Paper
0
Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy
Authors
Published
Jan 3, 2018
Show more
Save
Tip0
TipSave
Abstract
Maraba virus treatment before surgery for triple-negative breast cancer promotes antitumor immunity.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.